Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke Patients


Phase 1/2 Results N/A

Summary of Purpose

The purpose of this study is to determine whether autologous bone marrow mononuclear cells transplantation after stroke is safe and/or effective to improve neurological outcome.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 July 2013.

1 May 2008 8 Dec 2009 1 Jul 2013 1 Jul 2013 1 Jul 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment